MicroRNA Expression Profiling During Neural Differentiation of Mouse Embryonic Carcinoma P19 Cells

2012 ◽  
pp. 105-116 ◽  
Author(s):  
Botao Zhao ◽  
Bing Huang ◽  
Wei Li ◽  
Youxin Jin
Keyword(s):  
Expression Profiling ◽  
Neural Differentiation ◽  
Microrna Expression ◽  
P19 Cells ◽  
Embryonic Carcinoma

scholarly journals MicroRNA expression profiling during neural differentiation of mouse embryonic carcinoma P19 cells

2009 ◽  
Vol 41 (3) ◽  
pp. 231-236 ◽  
Author(s):  
Bing Huang ◽  
Wei Li ◽  
Botao Zhao ◽  
Caihong Xia ◽  
Ruqiang Liang ◽  
...  
Keyword(s):  
Expression Profiling ◽  
Neural Differentiation ◽  
Microrna Expression ◽  
P19 Cells ◽  
Embryonic Carcinoma

MicroRNA expression profiling in Acute myeloid leukemia patients

2009 ◽  
Vol 221 (03) ◽  
Author(s):  
S Daschkey ◽  
T Haferlach ◽  
A Borkhardt ◽  
P Landgraf
Keyword(s):  
Acute Myeloid Leukemia ◽  
Expression Profiling ◽  
Myeloid Leukemia ◽  
Microrna Expression ◽  
Acute Myeloid

scholarly journals Analysis of Circulating microRNA Signatures and Preeclampsia Development

Cells ◽  
2021 ◽  
Vol 10 (5) ◽  
pp. 1003
Author(s):  
Margarita L. Martinez-Fierro ◽  
Idalia Garza-Veloz
Keyword(s):  
Pregnant Women ◽  
Expression Profiling ◽  
Gene Prediction ◽  
Microrna Expression ◽  
Differentially Expressed ◽  
Control Group ◽  
Case Group ◽  
Circulating Microrna ◽  
Activated T Cells ◽  
Serum Microrna

microRNAs are important regulators of cell processes and have been proposed as potential preeclampsia biomarkers. We evaluated serum microRNA expression profiling to identify microRNAs involved in preeclampsia development. Serum microRNA expression profiling was evaluated at 12, 16, and 20 weeks of gestation (WG), and at the time of preeclampsia diagnosis. Two groups were evaluated using TaqMan low-density array plates: a control group with 18 normotensive pregnant women and a case group with 16 patients who developed preeclampsia during the follow-up period. Fifty-three circulating microRNAs were differentially expressed between groups (p < 0.05). Compared with controls, hsa-miR-628-3p showed the highest relative quantity values (at 12 WG = 7.7 and at 20 WG = 3.45) and the hsa-miRs -151a-3p and -573 remained differentially expressed from 16 to 20 WG (p < 0.05). Signaling pathways including cancer-related, axon guidance, Neurotrophin, GnRH, VEGF, and B/T cell receptor, were most commonly altered. Further target gene prediction revealed that nuclear factor of activated T-cells 5 gene was included among the transcriptional targets of preeclampsia-modulated microRNAs. Specific microRNAs including hsa-miRs -628-3p, -151a-3p, and -573 were differentially expressed in serum of pregnant women before they developed preeclampsia compared with controls and their participation in the preeclampsia development should be considered.

Sign in / Sign up

Export Citation Format

Share Document